About Gameto
Gameto is a company based in United States founded in 2020 by Dina Radenkovic and Martin Varsavsky. Gameto has raised $127 million across 5 funding rounds from investors including RA Capital, FJ Labs and Plum Alley Investments. Gameto offers products and services including Fertilo. Gameto operates in a competitive market with competitors including Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Naari, among others.
- Headquarter United States
- Founders Dina Radenkovic, Martin Varsavsky
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Gameto, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$127 M (USD)
in 5 rounds
-
Latest Funding Round
$44 M (USD), Series C
Aug 12, 2025
-
Investors
RA Capital
& 28 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Gameto
Gameto offers a comprehensive portfolio of products and services, including Fertilo.
iPSC-based treatment to enhance IVF success and reduce hormone use
People of Gameto
Unlock access to complete
Unlock access to complete
Funding Insights of Gameto
Gameto has successfully raised a total of $127M across 5 strategic funding rounds. The most recent funding activity was a Series C round of $44 million completed in August 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Gameto
Gameto has secured backing from 29 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include RA Capital, FJ Labs and Plum Alley Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments in tech sectors are managed by the firm.
|
Locked | Locked | Locked | |
|
Investment firm scaling software and technology companies from early to late stages.
|
Locked | Locked | Locked | |
|
Future Ventures is focused on early-stage venture capital investments.
|
Locked | Locked | Locked |
Investor details for Gameto
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Gameto
Investment portfolio details for Gameto
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Gameto
Detailed financials for Gameto
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Gameto Comparisons
Peer comparison for Gameto
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Gameto
Gameto operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sprout Pharmaceuticals, ObsEva, Hope Medicine, Rejoni and Naari, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Drugs for hypoactive sexual desire disorder in women are developed.
|
|
| Locked | Locked | Locked |
Therapeutics for women's reproductive health and pregnancy are developed.
|
|
| Locked | Locked | Locked |
Monoclonal antibodies are developed for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Therapeutics for women's health conditions are developed using innovative hydrogels.
|
|
| Locked | Locked | Locked |
Women care medicines are manufactured by Naari in India.
|
Detailed competitors of Gameto
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Gameto
Complete news archive for Gameto
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gameto
Gameto was founded in 2020.
Gameto is headquartered in United States.
Dina Radenkovic is the current CEO of Gameto. They have also founded this company.
Gameto is a funded company, having raised a total of $127M across 5 funding rounds to date.
Gameto was founded in 2020 in the United States as a biotechnology company. Therapeutics targeting fertility and menopause are developed to address womens health needs. Operations center on research and development of innovative treatments in these areas. The company is co-founded by Dina Radenkovic, who serves as CEO, and Martin Varsavsky. Focus remains on advancing solutions within the reproductive health sector.
Gameto's top competitors include Sprout Pharmaceuticals, Rejoni and Hope Medicine.
Gameto offers Fertilo.
Gameto has 29 investors. Key investors include RA Capital, FJ Labs, Plum Alley Investments, Two Sigma Ventures, and Insight Partners.